Impact of immunization technology and assay application on antibody performance - a systematic comparative evaluation

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Brown, Michael C ^a   Joaquim, Tony R ^a   Chambers, Ross ^a   Onisk, Dale V ^a   Yin, Fenglin ^a   Moriango, Janet M ^a   Xu, Yichun ^a   Fancy, David A ^a   Crowgey, Erin L ^a   He, Yida ^a   Stave, James W ^a   Lindpaintner, Klaus ^a  

^a SDIX   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; PEPTIDE ANTIBODY; PEPTIDE ANTIGEN; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; NONHUMAN; PROTEIN DENATURATION; PROTEIN PURIFICATION; PROTEIN TARGETING; RABBIT; WESTERN BLOTTING; ANIMAL; COMPARATIVE STUDY; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY;

ANIMALS; ANTIBODIES; IMMUNIZATION; IMMUNOLOGIC TECHNIQUES; RABBITS;

EID: 83755228610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028718     Document Type: Article

References (38)

1. Amin DN, Hida K, Bielenberg DR, Klagsbrun M, (2006) Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res 66: 2173-2180.
2. Garcia JF, Garcia JF, Maestre L, Lucas E, Sanchez-Verde L, et al. (2006) Genetic immunization: A new monoclonal antibody for the detection of BCL-6 protein in paraffin sections. Journal of Histochemistry & Cytochemistry 54 (1): 31-38.
3. Haab BB, (2005) Antibody arrays in cancer research. Molecular & Cellular Proteomics 4 (4): 377-383.
4. Li HH, Zhou G, Xiao-Bing F, Zhang L, (2009) Antigen expression in human endocrine sweat glands. Journal of Cutaneous Pathology 36: 318-324.
5. Schwenk JM, Lindberg J, Sundberg M, Uhlen M, Nilson P, (2007) Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Molecular & Cellular Proteomics 6 (1): 125-132.
6. Takahashi T, Imai K, Hashizume K, (2004) Generation and characterization of anti-leptin antisera against synthetic peptides and recombinant protein. Journal of Reproduction and Development 50 (6): 717-724.
7. Whiteaker JR, Zhao L, Abbatiello SE, Burgess M, Kuhn E, et al. (2011) Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Molecular & Cellular Proteomics 10 (4): M110.005645.
8. Laver WG, Air GM, Webster RG, Smith-Gill SJ, (1990) Epitopes on Protein antigens: Misconceptions and realities. Cell 61: 553-556.
9. Uhlen M, Ponten F, (2005) Antibody-based proteomics for human tissue profiling. Molecular & Cellular Proteomics 4 (4): 384-393.
10. Halperin RF, Stafford P, Johnston SA, (2011) Exploring antibody recognition of sequence space through random-sequence peptide microarrays. Molecular & Cellular Proteomics 10 (3): M110.000786.
11. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, et al. (2007) Conformation state-sensitive antibodies to G-protein-coupled receptors. Journal of Biological Chemistry 282: 5116-5124.
12. Nilsson P, Paavilainen L, Larsson K, Odling J, Sundberg M, et al. (2005) Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 5: 4327-4337.
13. Lindskog M, Rockberg J, Uhlen M, Sterky F, (2005) Selection of protein epitopes for antibody production. BioTechniques 38: 723-727.
14. Hurn BA, Chantler SM, (1980) Production of reagent antibodies. Methods Enzymol 70 (A): 104-142.
15. Tanaka T, Slamon DJ, Cline MJ, (1985) Efficient generation of antibodies to oncoproteins by using synthetic peptide antigens. Proc Natl Acad Sci 82: 3400-3404.
16. Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, et al. (1983) Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci 80: 4949-4953.
17. Blythe MJ, Flower DR, (2005) Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Science 14: 246-248.
18. Caoili SEC, (2010) Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: Problems and prospects. Journal of Biomedicine and Biotechnology 2010, Article ID 910524, 14 pages, doi:10.1155/2010/910524.
19. Liang S, Zheng D, Zhang C, Zacharias M, (2009) Prediction of antigenic epitopes on protein surfaces by consensus scoring. BMC Bioinformatics 10: 302-312.
20. Braun P, Hu Y, Shen B, Halleck A, Koundinya M, et al. (2002) Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci 99 (5): 2654-2659.
21. Chambers RS, Johnston SA, (2003) High-level generation of polyclonal antibodies by genetic immunization. Nature Biotechnology 21: 1088-1092.
22. Bates MK, Guofeng Z, Sebestyen MG, Neal ZC, Wolff JA, et al. (2006) Genetic immunization for antibody generation in research animals by intravenous delivery of plasmid DNA. Bio Techniques 40 (2): 199-207.
23. Alexandrenne C, Wijkhuisen A, Dkhissi F, Hanoux V, Creminon C, et al. (2009) Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: A comparison between DNA and protein immunizations. Journal of Immunological Methods 341: 41-49.
24. Takatsuka S, Sekiguchi A, Tokunaga M, Fujimoto A, Chiba J, (2010) Generation of a panel of monoclonal antibodies against atypical chemokine CCX-CKR by DNA immunization. Journal of Pharmacological and Toxicological Methods 63: 250-257.
25. Leinonen J, Niemela P, Lovgren J, Bocchii L, Pettersson K, et al. (2004) Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization. Journal of Immunological Methods 289: 157-167.
26. Kutzler MA, Weiner DB, (2008) DNA vaccines: ready for prime time? Nature Reviews Genetics 9: 776-789.
27. Wang S, Parker C, Taaffe J, Solórzano A, Adolfo García-Sastre A, et al. (2008) Heterologous HA DNA vaccine prime- inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 26 (29-30): 3626-3633.
28. Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, et al. (1998) Boosting with recombinant vaccinaia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci USA 95: 7648-7653.
29. Couchman JR, (2009) Commercial antibodies: The good, bad, and really ugly. Journal of Histochemistry & Cytochemistry 57 (1): 7-8.
30. Michel MC, Wieland T, Tsujimoto G, (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn-Schmied Arch Pharmacol 379: 385-388.
31. Rhodes KJ, Trimmer JS, (2008) Antibody-based validation of CNS ion channel drug targets. J Gen Physiol 131: 407-413.
32. Saper CB, Sawchenko PE, (2003) Magic peptides, magic antibodies: Guidelines for appropriate controls for immunohistochemistry. The Journal of Comparative Neurology 465: 161-163.
33. Bordeaux J, Welsh AW, Agarwal S, Killiam E, Baquero MT, et al. (2010) Antibody validation. Bio Techniques 48 (3): 197-209.
34. Coligan J, Bierer BE, Margulies DH, Shevach EM, Stober W, eds., eds (2008) Current Protocols in Immunology Volume 1 (Supplement 82) Hoboken John Wiley and Sons, Inc. Section 2.4.5.
35. Hermanson GT, Mallia AK, Smith PK, (1992) Immobilized Affinity Ligand Technique, Academic Press, CA.
36. Kolaskar AS, Tongaonkar PC, (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276 (1-2): 172-174.
37. Schwab C, Twardek A, Lo TP, Brayer GD, Bossard HR, (1993) Mapping antibody binding sites on cytochrome c with synthetic peptides: Are results representative of the antigenic structure of proteins? Protein Science 2 (2): 175-182.
38. Gershoni JM, Roitburd-Berman A, Siman-Tov DD, Tarnovitski-Freund N, Weiss Y, (2007) Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs 21 (3): 145-56.